NCT06637306 2025-03-26Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerIcahn School of Medicine at Mount SinaiPhase EARLY_PHASE1 Recruiting15 enrolled